Bristol-Myers Squibb Co. (BMY) PT Raised to $76 at Leerink Partners

February 6, 2018 6:16 AM EST Send to a Friend

Leerink Partners raised its price target on Bristol-Myers ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Bristol-Myers Squibb Co. (BMY) PT Raised to $76 at Leerink Partners

Member Login

Free News Feed